Be part of the knowledge.™

Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.

For more information about GOA, visit www.globaloncologyacademy.org.

797

LikeLikedUnlike

61-75 of 123

Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
MinuteCE®
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
- Giuseppe Curigliano, MD, PhD
1.00 program credits
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC 
MinuteCE®
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC 
- Giuseppe Curigliano, MD, PhD
- Komal Jhaveri, MD, FACP
1.00 program credits
The Future of Oral SERDs: Combination Strategies
MinuteCE®
The Future of Oral SERDs: Combination Strategies
- Komal Jhaveri, MD, FACP
1.00 program credits
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
MinuteCE®
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
- Komal Jhaveri, MD, FACP
1.00 program credits
Spotlight on Asia-Pacific: Practice Beyond Borders
MinuteCE®
Spotlight on Asia-Pacific: Practice Beyond Borders
- Hiraji Iwata, MD, PhD
1.00 program credits
Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
MinuteCE®
Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
- Luis Paz-Ares, MD, PhD
0.50 program credits
advertisement
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From ESMO 2025
MinuteCE®
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From ESMO 2025
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 program credits
MinuteCE®
Transformative Insights: Latest Evidence for B7-H3 ADCs From WCLC and ESMO 2025  
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 credits 6 episodes
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
MinuteCE®
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 program credits
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC 
MinuteCE®
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC 
- Lauren A. Byers, MD
0.50 program credits
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC 
MinuteCE®
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC 
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 program credits
Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
MinuteCE®
Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 program credits
advertisement
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
MinuteCE®
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits
MinuteCE®
Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 credits 9 episodes
The Current Therapeutic Landscape in Unresectable Stage III NSCLC
MinuteCE®
The Current Therapeutic Landscape in Unresectable Stage III NSCLC
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended